HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

In Brief: Alfin

This article was originally published in The Rose Sheet

Executive Summary

Alfin: Adrien Arpel President Adrienne Newman resigns Oct. 28, claiming breach of employment agreement, the company reported. Alfin maintains that it "has fully complied with all terms of the employment agreement and that the termination by Ms. Newman is itself a breach of the employment agreement." The company added, however, that it hopes to resolve the dispute peacefully. Alfin acquired Adrien Arpel as a wholly owned subsidiary in 1990. Newman founded the cosmetics business in 1962. Alfin posted sales for FY 1996 (ended July 31) of $34.7 mil., an increase of 8% over the prior-year period. Net earnings for the year increased 97.3% to $2.7 mil. from $1.4 mil in 1995...

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003395

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel